Literature DB >> 10922202

Comparison of different biomaterials for glaucoma drainage devices: part 2.

R S Ayyala1, B Michelini-Norris, A Flores, E Haller, C E Margo.   

Abstract

BACKGROUND: Inflammation associated with biomaterials may contribute to the failure of glaucoma drainage devices.
OBJECTIVE: To compare the inflammatory reaction associated with the insertion of Krupin silicone, Molteno polypropylene, and Acrosof end plates in the subconjunctival space of rabbits.
METHODS: Similar-sized glaucoma end plates made of 3 different biomaterials were sutured to the sclera in the superotemporal quadrant of the rabbit eye. Thirty eyes of 15 albino New Zealand rabbits were randomly assigned to the 3 groups. Conjunctival vascular hyperemia was graded in a masked fashion among the 3 groups. At the end of 3 weeks, the enucleated eyes were examined histologically and by scanning electron microscopy.
RESULTS: Molteno polypropylene was associated with more inflammation both in clinical observations and based on histological grading. Silicone and Acrosof were associated with less intense inflammation. One polypropylene end plate was extruded on day 21.
CONCLUSIONS: Polypropylene appears to be more inflammatory than silicone. Flexible biomaterials appear to be less inflammatory than rigid ones. CLINICAL RELEVANCE: Bleb failure following glaucoma drainage device implantation could be related to the biomaterial-associated inflammation. Choosing a biomaterial with the least inflammatory potential might enhance the success rate of the glaucoma drainage device. Arch Ophthalmol. 2000;118:1081-1084

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922202     DOI: 10.1001/archopht.118.8.1081

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  28 in total

1.  Assessing risk factors for postoperative hypotony in Ahmed glaucoma valve implantation surgery.

Authors:  Ahmet Kaderli; Gülizar Demirok; Güner Üney; Mehmet Yakın; Berku Günal; Ümit Ekşioğlu
Journal:  Int Ophthalmol       Date:  2021-05-21       Impact factor: 2.031

2.  Pars plana-modified Ahmed Glaucoma Valve for treatment of refractory glaucoma: a pilot study.

Authors:  Torsten Schlote; Focke Ziemssen; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-18       Impact factor: 3.117

3.  [Pathophysiology of fibrotic encapsulation of episcleral glaucoma drainage implants: modification for improvement of clinical results].

Authors:  L Choritz; M Wegner; R Förch; U Jonas; H Thieme
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

4.  The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis).

Authors:  Peter A Netland
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

5.  [STARflo-a suprachoroidal drainage implant in glaucoma surgery].

Authors:  S König; C W Hirneiß
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

6.  Efficacy and safety of the pars plana clip in the Ahmed valve device inserted via the pars plana in patients with refractory glaucoma.

Authors:  Manuel Diaz-Llopis; David Salom; Salvador García-Delpech; Patricia Udaondo; Jose Maria Millan; J Fernando Arevalo
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 7.  [Glaucoma drainage devices].

Authors:  H Thieme
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

8.  Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study.

Authors:  Y El Sayed; A Awadein
Journal:  Eye (Lond)       Date:  2013-04-12       Impact factor: 3.775

9.  MR imaging features of giant reservoir formation in the orbit: an unusual complication of Ahmed glaucoma valve implantation.

Authors:  T Y Jeon; H-J Kim; S T Kim; T-Y Chung; C Kee
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

10.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.